National Breast Cancer and Lymphedema Registry
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01580800 |
Recruitment Status :
Terminated
(Low enrollment, incomplete participant data, and follow-up information)
First Posted : April 19, 2012
Last Update Posted : June 29, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Breast Cancer Lymphedema |
Study Type : | Observational |
Actual Enrollment : | 549 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | National Breast Cancer and Lymphedema Registry |
Actual Study Start Date : | September 12, 2011 |
Actual Primary Completion Date : | March 2, 2018 |
Actual Study Completion Date : | March 2, 2018 |
Group/Cohort |
---|
Breast cancer survivors
Patients who have undergone breast cancer treatment (e.g. surgery, node dissection, chemotherapy and/or radiation therapy), and what affect this has had on their arm health.
|
- Preemptive diagnostic and treatment strategies [ Time Frame: Each enrolled patient will be followed for an average of 1 year ]The methods for lymphedema surveillance and detection will be correlated to the new appearance of lymphedema in this cohort of breast cancer survivors. We will also assess severity of lymphedema and responsiveness to treatment strategies.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Breast cancer survivorship
Exclusion Criteria:
- Age < 18 years old
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01580800
United States, California | |
Stanford University School of Medicine | |
Stanford, California, United States, 94305 |
Principal Investigator: | Stanley G Rockson | Stanford University |
Responsible Party: | Stanley Rockson, Allan and Tina Neill Professor of Lymphatic Research and Medicine, Stanford University |
ClinicalTrials.gov Identifier: | NCT01580800 |
Other Study ID Numbers: |
SU-10042011-8529 22349 ( Other Identifier: Stanford University ) |
First Posted: | April 19, 2012 Key Record Dates |
Last Update Posted: | June 29, 2018 |
Last Verified: | June 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Breast Neoplasms Lymphedema Neoplasms by Site Neoplasms |
Breast Diseases Skin Diseases Lymphatic Diseases |